Cognito Therapeutics secures $105 million in Series C funding led by Morningside Ventures to advance Spectris™ in Alzheimer’s disease.
Amount Raised
$105 Million
Round Type
Series C
CambridgeManufacturingBiotechnologyHealthcareHealth CareMedicalTherapeuticsInvestors
Description
Cognito Therapeutics has announced the close of its oversubscribed $105 million Series C funding. The financing will support pivotal study data readout, FDA submission, and commercialization in Alzheimer's disease by 2027. The round was led by Morningside Ventures, IAG Capital Partners, and Starbloom Capital. This funding will also aid in advancing additional neurodegenerative indications through their network of brain health collaboratories.
Quick answer
Cognito Therapeutics raised $105 Million in a Series C round, dated March 5, 2026. Investors: New Vintage, Starbloom Capital, Apollo Health Ventures, Benvolio Group, Morningside Ventures and IAG Capital Partners. Cognito Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Cognito Therapeutics raise?
- Cognito Therapeutics raised $105 Million in a Series C round on March 5, 2026.
- Who invested in Cognito Therapeutics?
- New Vintage, Starbloom Capital, Apollo Health Ventures, Benvolio Group, Morningside Ventures and IAG Capital Partners are named as investors in this round.
- What does Cognito Therapeutics do?
- Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance.
- Where is Cognito Therapeutics based and how big is it?
- Cognito Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 57 employees.
- Who are the decision-makers at Cognito Therapeutics?
- Fundz holds 5 contacts at Cognito Therapeutics, including the Vice President People Operations. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Medical around the same time
Companies in the same sectors as Cognito Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Route 92 Medical raised $50M (Funding Round) on April 7, 2026.
- Monteris Medical raised $28M (Series E) on March 12, 2026.
- Tenon Medical raised $4.3M on March 11, 2026.
- TransCode Therapeutics raised $20M (Funding Round) on April 7, 2026.
- TippingPoint Biosciences raised $4.5M (Seed) on March 31, 2026.
- Sonire Therapeutics raised $18M (Series A) on March 31, 2026.
Who to call at Cognito Therapeutics, and when
A new round usually means Cognito Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cognito Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cognito Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cognito Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cognito Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cognito Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.